Mark Masin
Impact in
- Immunology top 10%
- IL-33, ST2, and ILC Pathways
- Immune Response and Inflammation
- Immune Cell Function and Interaction
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Multiple Myeloma Research and Treatments 2
-
- Gout, Hyperuricemia, Uric Acid 1
- Co-authors
- Stefan K. Drexler (2 shared papers)Jürg Tschopp (2 shared papers)Amir Sadegh Yazdi (2 shared papers)O. Groß (2 shared papers)Leonhard X. Heinz (1 shared paper)Manfredo Quadroni (1 shared paper)Christina James Thomas (1 shared paper)Greta Guarda (1 shared paper)
- Journals
- Blood (1 paper)Immunity (1 paper)Proceedings of the National Academy of Sciences (1 paper)British Journal of Clinical Pharmacology (1 paper)PLoS Pathogens (1 paper)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Mark Masin
7 papers receiving 788 citations
Mark Masin's Hit Papers
Peers
Comparison fields: 5 of 76
- Immunology 294
- Cancer Research 105
- Molecular Biology 483
- Nephrology 45
- Infectious Diseases 94
Countries citing papers authored by Mark Masin
This map shows the geographic impact of Mark Masin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Masin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Masin more than expected).
Fields of papers citing papers by Mark Masin
This network shows the impact of papers produced by Mark Masin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Masin. The network helps show where Mark Masin may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Masin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inflammasome Activators Induce Interleukin-1α Secretion via Distinct Pathways with Differential Requirement for the Protease Function of Caspase-1 Hit paper breakdown → | 2012 | 400 |
| 2 | 2014 | 132 | |
| 3 | 2011 | 128 | |
| 4 | 2012 | 122 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 6 | |
| 7 | GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer | 2014 | 1 |
About Mark Masin
Mark Masin is a scholar working on Hematology, Nephrology, Molecular Biology, Cancer Research and Infectious Diseases, having authored 7 papers that have together received 798 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (2 papers), Multiple Myeloma Research and Treatments (2 papers), Gout, Hyperuricemia, Uric Acid (1 paper), RNA modifications and cancer (1 paper), Protein Degradation and Inhibitors (1 paper), Metabolism, Diabetes, and Cancer (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Immunology (294 citations), Cancer Research (105 citations), Molecular Biology (483 citations), Nephrology (45 citations) and Infectious Diseases (94 citations). Mark Masin has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Stefan K. Drexler, Jürg Tschopp, Amir Sadegh Yazdi, O. Groß, Leonhard X. Heinz, Manfredo Quadroni, Christina James Thomas, Greta Guarda, Stefan Kunz and Jillian M. Rojek. Their work appears in journals such as Blood, Immunity, Proceedings of the National Academy of Sciences, British Journal of Clinical Pharmacology and PLoS Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.